At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing Reference.
Studies have shown immediate-release opioids can be used supplementally when transdermal buprenorphine is being used to manage moderate-to-severe chronic pain.
The study cleared up confusion as whether or not immediate-release opioids would properly function with buprenorphine, which may displace or prevent competing mu-opioid agonists from binding.
More Articles on Anesthesia:
Clinical Trial Shows Drug EXPAREL Reduces Pain, Adverse Opioid Side Effects
Donald Bell Named First CRNA to Chair Tennessee Board of Nursing
Sheridan Healthcare Names Dr. Andrew Greenfield Senior VP of Anesthesiology
Studies have shown immediate-release opioids can be used supplementally when transdermal buprenorphine is being used to manage moderate-to-severe chronic pain.
The study cleared up confusion as whether or not immediate-release opioids would properly function with buprenorphine, which may displace or prevent competing mu-opioid agonists from binding.
More Articles on Anesthesia:
Clinical Trial Shows Drug EXPAREL Reduces Pain, Adverse Opioid Side Effects
Donald Bell Named First CRNA to Chair Tennessee Board of Nursing
Sheridan Healthcare Names Dr. Andrew Greenfield Senior VP of Anesthesiology